"The Gastroenterology Group of Northern New Jersey represents the premier gastroenterology practice in the region. Our physicians have come together with a goal of providing excellence in clinical care in a safe and compassionate environment. We provide care in all aspects of gastrointestinal diseases."

During the past decade, The Gastroenterology Group of Northern NJ LLC conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "The Gastroenterology Group of Northern NJ LLC" are "Colitis, Ulcerative" (1 trials), "Heartburn" (1 trials) and "Non-Erosive Gastro-Esophageal Reflux Disease" (1 trials). Many other conditions were trialed in "The Gastroenterology Group of Northern NJ LLC" in a lesser frequency.

Most popular intervention types in "The Gastroenterology Group of Northern NJ LLC" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ozanimod" (1 trials), "Placebo" (1 trials) and "Vonoprazan" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Gastroenterology Group of Northern NJ LLC" are 2 trials for "All" genders.

Currently, there are NaN active trials in "The Gastroenterology Group of Northern NJ LLC". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in The Gastroenterology Group of Northern NJ LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Gastroenterology Group of Northern NJ LLC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".